Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone
NCT06537180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 621
Last updated 2024-08-06
Summary
The aim of this study is to explore the gender-based differences in the outcomes of treatment with hydrocortisone in critically ill patients with persistent septic shock.
Conditions
- Septic Shock
Sponsors & Collaborators
-
Alexandria University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-01
- Primary Completion
- 2023-07-30
- Completion
- 2024-08-01
Countries
- Egypt
Study Locations
More Related Trials
-
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
NCT05402553 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock
NCT01150409 ·Status: TERMINATED ·Phase: PHASE4
-
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
NCT00368381 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
NCT02114710 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.
NCT01817153 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock
NCT01448109 ·Status: COMPLETED ·Phase: PHASE4
-
Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
NCT02266589 ·Status: COMPLETED ·Phase: PHASE3
-
Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock.
NCT02768740 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Septic Shock em Steroids
NCT01047670 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
NCT05818826 ·Status: RECRUITING ·Phase: PHASE2
-
Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock
NCT00320099 ·Status: COMPLETED ·Phase: PHASE3
-
Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock
NCT07313670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension
NCT05774054 ·Status: COMPLETED ·Phase: NA
-
Interstitial Fluid Composition in Patients With Septic Versus Non-septic Shock: an Exploratory Pilot Study
NCT05039151 ·Status: COMPLETED
-
Fluid Responseveness in Sepsis and Its Correlation to CVP
NCT05612529 ·Status: TERMINATED
-
Observational Study About the Use of Perfusion Index to Use Vasopressor in Sepsis
NCT06860438 ·Status: RECRUITING
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
NCT05813951 ·Status: UNKNOWN ·Phase: NA
-
Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis
NCT00185783 ·Status: COMPLETED
-
CO2 Gap Changes in Septic Shock in Relation to Cardiac Output
NCT05578534 ·Status: COMPLETED
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 ·Status: COMPLETED
-
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
NCT04049565 ·Status: COMPLETED
-
Role of Early Point of Care Ultrasound in Management of Sepsis in Emergency Department
NCT05849194 ·Status: COMPLETED ·Phase: NA